EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of the In Vivo Skin Penetration of TXVector by Confocal Raman Spectroscopy

Daniel Winn, Andrea Gilreath, David Pajuelo, Justyna M Meissner, Jose L Mullor

Journal of Cosmetic Dermatology · 2025

DOI: 10.1111/jocd.16696 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cosmetic Dermatology, 2025. Verfasst von Daniel Winn und 4 weiteren Autor:innen. Beteiligte Einrichtung: Actera Ingredients Inc, Newtown, Pennsylvania, USA. Hauptthemen laut MEDLINE: Tranexamic Acid, Skin, Skin Absorption. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Tranexamic acid (TXA) is a promising active to treat hyperpigmentation disorders, such as melasma and acne scars. However, TXA is highly hydrophilic and its penetration into the skin is poor and formulation dependent.

Aims

In this study, our aim was to evaluate the in vivo skin penetration of an ester‐modified TXA, TXVector, directly on the skin of volunteers.

Methods

For the analysis of in vivo skin penetration of TXVector, we used in vivo confocal Raman spectroscopy (CRS). The use of CRS on live skin allows us to study directly how a compound affects skin composition at different depths and how this compound penetrates into the skin in real time.

Results

Our results showed that the TXA absorption into the skin via TXVector was 2.1‐fold and 3.8‐fold higher compared to free TXA 3% and TXA 1% formulations, respectively. Most importantly, upon application of TXVector, the TXA penetration flux into the skin was 107% and 280% higher than that of the free TXA 3% and TXA 1% formulations, respectively.

Conclusions

In summary, this study shows that the esterification‐based TXVector formulation enhances the penetration flux of TXA and increases its bioavailability in the skin.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tranexamic AcidSkinSkin AbsorptionHumansSpectrum Analysis, RamanFemaleAdultAdministration, CutaneousMale

Stichwörter der Autor:innen

Raman spectroscopyhyperpigmentationin vivoskin penetrationtranexamic acid

Substanzen

Tranexamic Acid

Autor:innen und Institutionen

  • Actera Ingredients Inc, Newtown, Pennsylvania, USA.
  • Bionos Biotech S.L., LabAnalysis Life Science, S.r.L., Biopolo La Fe, IIS La Fe, Valencia, Spain.

Zitieren

APA

Winn, D., Gilreath, A., Pajuelo, D., Meissner, J. M., & Mullor, J. L. (2025). Evaluation of the In Vivo Skin Penetration of TXVector by Confocal Raman Spectroscopy. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.16696

Vancouver

Winn D, Gilreath A, Pajuelo D, Meissner JM, Mullor JL. Evaluation of the In Vivo Skin Penetration of TXVector by Confocal Raman Spectroscopy. Journal of Cosmetic Dermatology. 2025. doi:10.1111/jocd.16696

BibTeX
@article{Winn2025,
  author = {Winn, Daniel and Gilreath, Andrea and Pajuelo, David and Meissner, Justyna M and Mullor, Jose L},
  title = {Evaluation of the In Vivo Skin Penetration of TXVector by Confocal Raman Spectroscopy},
  journal = {Journal of Cosmetic Dermatology},
  year = {2025},
  doi = {10.1111/jocd.16696}
}
Kostenlos starten →